BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 19356483)

  • 1. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2* magnetic resonance: iron and gold.
    Pennell DJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):579-81. PubMed ID: 19356484
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of cardiac MRI T2* with echocardiography in thalassemia major.
    Barzin M; Kowsarian M; Akhlaghpoor S; Jalalian R; Taremi M
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):254-60. PubMed ID: 22428478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of ventricular dysfunction by tissue Doppler echocardiography related to cardiac iron overload in patients with thalassemia.
    Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Srichairatanakool S
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):91-98. PubMed ID: 32728990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
    Bayraktaroğlu S; Aydinok Y; Yildiz D; Uluer H; Savaş R; Alper H
    Diagn Interv Radiol; 2011 Dec; 17(4):346-51. PubMed ID: 21647857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2* magnetic resonance and myocardial iron in thalassemia.
    Pennell DJ
    Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial iron load and fibrosis in long term survivors of childhood leukemia.
    Cheung YF; Lam WW; Ip JJ; Cheuk DK; Cheng FW; Yang JY; Yau JP; Ho KK; Li CK; Li RC; Yuen HL; Ling AS; Li VW; Chan GC
    Pediatr Blood Cancer; 2015 Apr; 62(4):698-703. PubMed ID: 25557466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging.
    Seldrum S; Pierard S; Moniotte S; Vermeylen C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2011 Apr; 13(1):23. PubMed ID: 21518461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.
    Anderson LJ; Westwood MA; Holden S; Davis B; Prescott E; Wonke B; Porter JB; Walker JM; Pennell DJ
    Br J Haematol; 2004 Nov; 127(3):348-55. PubMed ID: 15491298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
    Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
    J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance.
    Aypar E; Alehan D; Hazirolan T; Gümrük F
    Int J Cardiovasc Imaging; 2010 Apr; 26(4):413-21. PubMed ID: 20127175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal diastolic function and Global longitudinal strain in patients with Thalassemia Major on long term chelation therapy.
    Nadar SK; Daar S; Abdelmottaleb WA; Shaikh MM; Al Mahrouqi H; Al-Raiisi M; Hassan M; Al Rawahi B; Al Rahbi S
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):643-649. PubMed ID: 32965605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of deferasirox for reducing total body and cardiac iron in thalassemia.
    Merchant R; Ahmed J; Krishnan P; Jankharia B
    Indian Pediatr; 2012 Apr; 49(4):281-5. PubMed ID: 21992861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload.
    Smith GC; Alpendurada F; Carpenter JP; Alam MH; Berdoukas V; Karagiorga M; Ladis V; Piga A; Aessopos A; Gotsis ED; Tanner MA; Westwood MA; Galanello R; Roughton M; Pennell DJ
    J Cardiovasc Magn Reson; 2011 Jul; 13(1):34. PubMed ID: 21733147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients.
    Abtahi F; Abdi A; Jamshidi S; Karimi M; Babaei-Beigi MA; Attar A
    Cardiovasc Ultrasound; 2019 Nov; 17(1):24. PubMed ID: 31684963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of left atrial contractile function: a herald of iron overload in patients with beta thalassemia major.
    Shabanian R; Heidari-Bateni G; Kocharian A; Mashayekhi M; Hosseinzadeh S; Kiani A; Izadyar M; Koochakzadeh L
    Pediatr Cardiol; 2010 Jul; 31(5):680-8. PubMed ID: 20383704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.